Assura (LON:AGR) Given “Hold” Rating at Shore Capital

Shore Capital reiterated their hold rating on shares of Assura (LON:AGR) in a report issued on Wednesday, Marketbeat reports.

Separately, Peel Hunt reiterated a “buy” rating and issued a GBX 60 price target on shares of Assura in a research report on Tuesday. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of GBX 60.

Assura Stock Up 0.4%

LON AGR opened at GBX 47.48 on Wednesday. The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05. Assura has a 1-year low of GBX 35.24 and a 1-year high of GBX 50.95. The company has a 50 day moving average of GBX 47.94 and a 200-day moving average of GBX 48.48. The company has a market cap of £1.54 billion, a price-to-earnings ratio of 895.85, a PEG ratio of 3.60 and a beta of 0.37.

Assura (LON:AGR) last released its quarterly earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 earnings per share for the quarter. Assura had a negative net margin of 18.09% and a negative return on equity of 1.92%. On average, equities research analysts expect that Assura will post 3.5830389 earnings per share for the current fiscal year.

Insider Activity

In other Assura news, insider Sam Barrell sold 34,153 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of GBX 48, for a total transaction of £16,393.44. Also, insider Jonathan Murphy sold 1,572,585 shares of the business’s stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of GBX 50, for a total transaction of £786,292.50. In the last three months, insiders have acquired 2,540 shares of company stock valued at $125,674 and have sold 5,182,149 shares valued at $258,872,495. Corporate insiders own 0.93% of the company’s stock.

About Assura

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.